Abingworth Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 16

Professionals

  • Investments
  • 260

  • Portfolio
  • 33

  • Exits
  • 156

Exits

Abingworth General Information

Company Description

Founded in 1973, Abingworth is a venture capital firm based in London, United Kingdom. The firm prefers to invest in seed-stage, early-stage, growth-stage, and later-stage companies. The firm seeks to invest in healthcare, information technology, life science, and technology-based sectors in the United States and Europe.

Business Details

Website
www.abingworth.com
Year Founded
1973
Investor Status
Actively Seeking New Investments
Trade Association
British Venture Capital Association (BRVCA)
New England Venture Capital Association (NEVCA)
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Corporate Office
  • 38 Jermyn Street
  • London SW1Y 6DN
  • England, United Kingdom
+44 020 0000 0000

Abingworth Investments & Acquisitions (260)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Scorpion Therapeutics 16-Jul-2024 Later Stage VC 00000 Drug Discovery Generating Revenue
Myricx Bio 08-Jul-2024 00000 00000 00000 Drug Discovery Generating Revenue 0000000 0000
Iambic Therapeutics 04-Jun-2024 00000 00000 0000 Drug Discovery Clinical Trials - Phase 1
Teva Pharmaceutical Industries 17-Apr-2024 0000 00000 Pharmaceuticals Generating Revenue/Not Profitable
Q32 Bio 25-Mar-2024 0000 0000 Drug Discovery Generating Revenue 000000 00000
Iambic Therapeutics 28-Sep-2023 00000 00000 00000 Drug Discovery Clinical Trials - Phase 1
Addition Therapeutics 15-Sep-2023 00000 00000 0000 Biotechnology Stealth
Ascend Gene And Cell Therapies 08-May-2023 00000 00000 00000 Biotechnology Startup 0000 0000000
Reneo Pharmaceuticals 08-May-2023 PIPE 000 Drug Discovery Generating Revenue/Not Profitable 0000 0000000
Soleno Therapeutics 08-May-2023 PIPE 0000 Other Devices and Supplies Generating Revenue/Not Profitable
You’re viewing 10 of 260 investments and acquisitions. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Abingworth Exits (156)

Company Name Exit Date Exit Type Exit Size
Escient Pharmaceuticals 23-Apr-2024 Merger/Acquisition 00000
Pixium Vision 31-Jan-2024 0000000000:
Sierra Oncology 01-Jul-2022 000000000000 00.00
HilleVax 29-Apr-2022 000 00000
Vera Therapeutics 10-Feb-2022 000000 00000 000.00
Adaptate Biotherapeutics 10-Jan-2022 000000000000
GammaDelta Therapeutics 27-Oct-2021 000000000000
Entero Therapeutics 22-Sep-2021 0000000 0000 00000
Effector Therapeutics 25-Aug-2021 Reverse Merger 00000
Avillion 01-Jul-2021 Secondary Transaction - Private
You’re viewing 10 of 156 exits. Get the full list »

Abingworth Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore Abingworth‘s full profile, request access.

Request a free trial

Abingworth Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Abingworth Management, Team & Partners (51)

Name Title Deals Funds Boards Office
Neil Cooper Chief Financial Officer London, United Kingdom
Andrew Sinclair Ph.D Managing Director 0 0 0 London, United Kingdom
Emily Janvey MD Managing Director London, United Kingdom
Jayson Punwani Ph.D Managing Director 0 0 0 London, United Kingdom
Joy Ghosh Ph.D Managing Director 0 London, United Kingdom
You’re viewing 5 of 51 team members. Get the full list »

Abingworth Co-Investors (154)

Name With Exits Lead Partner Series Industry
Citadel Enterprise Americas 4 0 Series chart Industry bar
Novo Holdings 0 0 Series chart Industry bar
OrbiMed 0 0 Series chart Industry bar
Osage University Partners 0 0 0 Series chart Industry bar
RiverVest Venture Partners 0 0 Series chart Industry bar
You’re viewing 5 of 154 co-investors. Get the full list »

Abingworth FAQs

  • What is Abingworth?

    Founded in 1973, Abingworth is a venture capital firm based in London, United Kingdom.

  • When was Abingworth founded?

    Abingworth was founded in 1973.

  • Where is Abingworth headquartered?

    Abingworth is headquartered in London, United Kingdom.

  • What is Abingworth's total asset value?

    Abingworth has around 00.000 in total assets under management.

  • How many investments has Abingworth made?

    Abingworth has made 260 investments.

  • What has Abingworth invested in?

    Abingworth has made numerous investments in companies like Scorpion Therapeutics, Myricx Bio, and Iambic Therapeutics within the Drug Discovery industry.

  • What has Abingworth invested in recently?

    Abingworth's latest investment was on 16-Jul-2024 in Scorpion Therapeutics, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »